Literature DB >> 32642858

A novel homozygous mutation (p.N958K) of SLC12A3 in Gitelman syndrome is associated with endoplasmic reticulum stress.

W Tang1, X Huang2, Y Liu3, Q Lv1, T Li1, Y Song1, X Zhang1, X Chen4, Y Shi5.   

Abstract

PURPOSE: Gitelman syndrome (GS) is an autosomal recessive renal tubular disease that arises as a consequence of mutations in the SLC12A3 gene, which codes for an Na-Cl cotransporter (NCC) in distal renal tubules. This study was designed to explore the mutations associated with GS in an effort to more fully understand the molecular mechanisms governing GS.
METHODS: We analyzed SLC12A3 mutations in a pedigree including a 42-year-old male with GS as well as four related family members over three generations using Sanger and next generation sequencing approaches. We additionally explored the functional ramifications of identified mutations using both Xenopus oocytes and the HEK293T cell line.
RESULTS: We found that the subject with GS exhibited characteristic symptoms including sporadic thirst, fatigue, excess urination, and substantial hypokalemia and hypocalciuria, although magnesium levels were normal. Other analyzed subjects in this pedigree had normal laboratory findings and did not exhibit clear signs of GS. Sequencing analyses revealed that the GS subject exhibited a homozygous missense mutation (c.2874C > G, p.N958K) in exon 24 of SLC12A3. Both parents of this GS subject, as well as his older brother and daughter all exhibited heterozygous mutations at this same site. Functional analyses in Xenopus oocytes indicated that this mutated SLC12A3 gene encodes a protein which fails to mediate normal sodium transport, and when this mutant gene was expressed in HEK293T cells, we observed significant increases in endoplasmic reticulum (ER)-stress pathway activation.
CONCLUSION: The p.N958K mutation in exon 24 of SLC12A3 can trigger GS at least in part via enhancing ER stress responses.

Entities:  

Keywords:  Endoplasmic reticulum stress; Gitelman syndrome; SLC12A3 gene mutation

Year:  2020        PMID: 32642858     DOI: 10.1007/s40618-020-01329-y

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

1.  Gitelman syndrome: novel mutation and long-term follow-up.

Authors:  Aditi Sinha; Petr Lněnička; Biswanath Basu; Ashima Gulati; Pankaj Hari; Arvind Bagga
Journal:  Clin Exp Nephrol       Date:  2011-10-04       Impact factor: 2.801

2.  Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome.

Authors:  Eva Riveira-Munoz; Qing Chang; Nathalie Godefroid; Joost G Hoenderop; René J Bindels; Karin Dahan; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2007-02-28       Impact factor: 10.121

3.  A novel heterozygous duplication of the SLC12A3 gene in two Gitelman syndrome pedigrees: indicating a founder effect.

Authors:  Pavlos Fanis; Elisavet Efstathiou; Vassos Neocleous; Leonidas A Phylactou; Adamos Hadjipanayis
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

4.  Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life.

Authors:  D N Cruz; A J Shaer; M J Bia; R P Lifton; D B Simon
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

5.  Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.

Authors:  Anne Blanchard; Rosa Vargas-Poussou; Marion Vallet; Aurore Caumont-Prim; Julien Allard; Estelle Desport; Laurence Dubourg; Matthieu Monge; Damien Bergerot; Stéphanie Baron; Marie Essig; Frank Bridoux; Ivan Tack; Michel Azizi
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

Review 6.  A novel SLC12A3 gene homozygous mutation of Gitelman syndrome in an Asian pedigree and literature review.

Authors:  Q Lü; Y Zhang; C Song; Z An; S Wei; J Huang; L Huang; L Tang; N Tong
Journal:  J Endocrinol Invest       Date:  2015-08-11       Impact factor: 4.256

7.  Novel mutation in the SLC12A3 gene in a Sri Lankan family with Gitelman syndrome & coexistent diabetes: a case report.

Authors:  Chandrika Jayakanthi Subasinghe; Nirmala Dushyanthi Sirisena; Chula Herath; Knut Erik Berge; Trond Paul Leren; Uditha Bulugahapitiya; Vajira Harshadeva Weerabaddana Dissanayake
Journal:  BMC Nephrol       Date:  2017-04-26       Impact factor: 2.388

8.  Novel heterozygous missense mutation of SLC12A3 gene in Gitelman syndrome: A case report.

Authors:  Cheng-Lin Wang
Journal:  World J Clin Cases       Date:  2019-06-26       Impact factor: 1.337

Review 9.  Gitelman syndrome.

Authors:  Nine V A M Knoers; Elena N Levtchenko
Journal:  Orphanet J Rare Dis       Date:  2008-07-30       Impact factor: 4.123

10.  A case of hypokalemia and proteinuria with a new mutation in the SLC12A3 Gene.

Authors:  Qin Chen; Yaqin Wu; Jingya Zhao; Ying Jia; Wei Wang
Journal:  BMC Nephrol       Date:  2018-10-19       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.